Logo image of MUX

MCEWEN MINING INC (MUX) Stock Fundamental Analysis

NYSE:MUX - New York Stock Exchange, Inc. - US58039P3055 - Common Stock - Currency: USD

8.03  -0.05 (-0.62%)

After market: 8.04 +0.01 (+0.12%)

Fundamental Rating

3

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of MUX have multiple concerns. MUX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MUX had negative earnings in the past year.
MUX had a positive operating cash flow in the past year.
MUX had negative earnings in 4 of the past 5 years.
In the past 5 years MUX reported 4 times negative operating cash flow.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

MUX has a Return On Assets (-4.05%) which is comparable to the rest of the industry.
MUX has a Return On Equity of -6.16%. This is comparable to the rest of the industry: MUX outperforms 43.79% of its industry peers.
Industry RankSector Rank
ROA -4.05%
ROE -6.16%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

MUX's Gross Margin of 20.71% is in line compared to the rest of the industry. MUX outperforms 59.48% of its industry peers.
MUX's Gross Margin has improved in the last couple of years.
MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MUX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MUX has more shares outstanding
The debt/assets ratio for MUX has been reduced compared to a year ago.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MUX has an Altman-Z score of -1.18. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
MUX has a Altman-Z score of -1.18. This is amonst the worse of the industry: MUX underperforms 86.27% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.
MUX's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. MUX outperforms 40.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -1.18
ROIC/WACCN/A
WACC8.82%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MUX has a Current Ratio of 2.35. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.35, MUX is in line with its industry, outperforming 54.90% of the companies in the same industry.
MUX has a Quick Ratio of 1.89. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.89, MUX is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.89
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.08% over the past year.
The Revenue has decreased by -2.18% in the past year.
Measured over the past years, MUX shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.
EPS 1Y (TTM)52.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-13.42%

3.2 Future

MUX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.27% yearly.
MUX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 86.64% yearly.
EPS Next Y92.94%
EPS Next 2Y79.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.69%
Revenue Next 2Y-17.52%
Revenue Next 3Y86.64%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MUX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.67, which indicates a very decent valuation of MUX.
Based on the Price/Forward Earnings ratio, MUX is valued a bit cheaper than 70.59% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, MUX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.67
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

MUX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.7
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MUX's earnings are expected to grow with 79.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.27%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MUX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MCEWEN MINING INC

NYSE:MUX (5/30/2025, 8:18:16 PM)

After market: 8.04 +0.01 (+0.12%)

8.03

-0.05 (-0.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners30.74%
Inst Owner Change30.44%
Ins Owners0.47%
Ins Owner Change0.09%
Market Cap433.54M
Analysts80
Price Target15.36 (91.28%)
Short Float %10.16%
Short Ratio5.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100.17%
Min EPS beat(2)-197.03%
Max EPS beat(2)-3.31%
EPS beat(4)1
Avg EPS beat(4)-47.52%
Min EPS beat(4)-197.03%
Max EPS beat(4)64%
EPS beat(8)4
Avg EPS beat(8)-30.3%
EPS beat(12)5
Avg EPS beat(12)-77.69%
EPS beat(16)6
Avg EPS beat(16)-127.74%
Revenue beat(2)1
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)7.08%
Revenue beat(8)6
Avg Revenue beat(8)1.12%
Revenue beat(12)6
Avg Revenue beat(12)-4.27%
Revenue beat(16)7
Avg Revenue beat(16)-3.95%
PT rev (1m)3.43%
PT rev (3m)-23.64%
EPS NQ rev (1m)85.71%
EPS NQ rev (3m)90.48%
EPS NY rev (1m)83.33%
EPS NY rev (3m)80.3%
Revenue NQ rev (1m)13.79%
Revenue NQ rev (3m)6.03%
Revenue NY rev (1m)-36.06%
Revenue NY rev (3m)-39.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.67
P/S 2.57
P/FCF N/A
P/OCF 18.34
P/B 0.9
P/tB 0.9
EV/EBITDA 20.7
EPS(TTM)-0.69
EYN/A
EPS(NY)0.75
Fwd EY9.37%
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)0.44
OCFY5.45%
SpS3.13
BVpS8.89
TBVpS8.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.05%
ROE -6.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.71%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 5.54
Cap/Depr 183.98%
Cap/Sales 32.23%
Interest Coverage N/A
Cash Conversion 104.34%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.89
Altman-Z -1.18
F-Score4
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y92.94%
EPS Next 2Y79.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-13.42%
Revenue Next Year-28.69%
Revenue Next 2Y-17.52%
Revenue Next 3Y86.64%
Revenue Next 5YN/A
EBIT growth 1Y90.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.02%
OCF growth 3YN/A
OCF growth 5YN/A